nach oben

World Journal of Urology

Erschienen in:

10.07.2019 | Topic Paper

Robotic enucleation of adrenal masses: technique and outcomes

verfasst von: Chen Ye, Yue Yang, Fei Guo, Fubo Wang, Chao Zhang, Bo Yang

Erschienen in: World Journal of Urology | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To evaluate the feasibility and safety of the application of robotic enucleation of adrenal masses (REAM).

Methods

Thirteen patients at Shanghai Changhai Hospital who underwent robotic enucleation of adrenal mass from February 2017 to March 2018 were reviewed. After mobilizing the adrenal gland and clamping the feeding blood vessels, the tumor was enucleated and reconstruction was performed. Relevant clinical data were recorded including baseline patient and tumor characteristics, and perioperative outcomes (operating time, ischemic time, estimated blood loss, complications, and so on).

Results

All cases were successfully completed without conversion to total adrenalectomy or open surgery. The mean operative time was 75 min (range 60–95), with a mean warm ischemia time of 12 min (range 8–17). The estimated blood loss was 20 mL (range 10–50). No intraoperative complications were observed, and no steroid replacement was given post-operatively. After a median follow-up period of 12 months (range 9–15), no evidence of disease recurrence was detected.

Conclusions

Robotic enucleation of adrenal masses is a safe and feasible procedure with excellent short-term functional and oncologic outcomes. Steroid supplementation is not necessary and recurrence is not usual with limited follow-up. Long-term follow-up and larger studies should be conducted to further evaluate outcomes of this robotic adrenal-sparing approach.

Nehs MA, Ruan DT (2011) Minimally invasive adrenal surgery: an update. Curr Opin Endocrinol Diabetes Obes 18(3):193–197. https://doi.org/10.1097/MED.0b013e32834693bfCrossRefPubMed

Wang HS, Li CC, Chou YH, Wang CJ, Wu WJ, Huang CH (2009) Comparison of laparoscopic adrenalectomy with open surgery for adrenal tumors. Kaohsiung J Med Sci 25(8):438–444. https://doi.org/10.1016/s1607-551x(09)70539-xCrossRefPubMed

Hall DW, Raman JD (2010) Has laparoscopy impacted the indications for adrenalectomy? Curr Urol Rep 11(2):132–137. https://doi.org/10.1007/s11934-009-0089-5CrossRefPubMed

Ball MW, Hemal AK, Allaf ME (2017) International Consultation on Urological Diseases and European Association of Urology International Consultation on Minimally Invasive Surgery in Urology: laparoscopic and robotic adrenalectomy. BJU Int 119(1):13–21. https://doi.org/10.1111/bju.13592CrossRefPubMed

Kaye DR, Storey BB, Pacak K, Pinto PA, Linehan WM, Bratslavsky G (2010) Partial adrenalectomy: underused first line therapy for small adrenal tumors. J Urol 184(1):18–25. https://doi.org/10.1016/j.juro.2010.03.052CrossRefPubMedPubMedCentral

Diner EK, Franks ME, Behari A, Linehan WM, Walther MM (2005) Partial adrenalectomy: The National Cancer Institute experience. Urology 66(1):19–23. https://doi.org/10.1016/j.urology.2005.01.009CrossRefPubMed

Davison AS, Jones DM, Ruthven S, Helliwell T, Shore SL (2018) Clinical evaluation and treatment of phaeochromocytoma. Ann Clin Biochem 55(1):34–48. https://doi.org/10.1177/0004563217739931CrossRefPubMed

Pavan N, Derweesh I, Rassweiler J, Challacombe B, Zargar H, Porter J, Liatsikos E, Kaouk J, Porpiglia F, Autorino R (2017) Contemporary minimally invasive surgery for adrenal masses: it's not all about (pure) laparoscopy. BJU Int 119(2):201–203. https://doi.org/10.1111/bju.13701CrossRefPubMed

Telenius-Berg M, Ponder MA, Berg B, Ponder BA, Werner S (1989) Quality of life after bilateral adrenalectomy in MEN 2. Henry Ford Hosp Med J 37(3–4):160–163PubMed

10.

Walther MM, Keiser HR, Choyke PL, Rayford W, Lyne JC, Linehan WM (1999) Management of hereditary pheochromocytoma in von Hippel-Lindau kindreds with partial adrenalectomy. J Urol 161(2):395–398CrossRef

11.

Chen SF, Chueh SC, Wang SM, Wu VC, Pu YS, Wu KD, Huang KH (2014) Clinical outcomes in patients undergoing laparoscopic adrenalectomy for unilateral aldosterone producing adenoma: partial versus total adrenalectomy. J Endourol 28(9):1103–1106. https://doi.org/10.1089/end.2014.0102CrossRefPubMed

12.

Jeschke K, Janetschek G, Peschel R, Schellander L, Bartsch G, Henning K (2003) Laparoscopic partial adrenalectomy in patients with aldosterone-producing adenomas: indications, technique, and results. Urology 61(1):69–72CrossRef

13.

Wang L, Cai C, Liu B, Yang Q, Wu Z, Xiao L, Yang B, Chen W, Xu Z, Song S, Sun Y (2013) Perioperative outcomes and cosmesis analysis of patients undergoing laparoendoscopic single-site adrenalectomy: a comparison of transumbilical, transperitoneal subcostal, and retroperitoneal subcostal approaches. Urology 82(2):358–364. https://doi.org/10.1016/j.urology.2013.03.060CrossRefPubMed

14.

Ho CH, Liao PW, Lin VC, Jaw FS, Chueh SC, Chung SD, Liu SP, Tsai YC, Yu HJ (2015) Laparoendoscopic single-site (LESS) retroperitoneal partial adrenalectomy using a custom-made single-access platform and standard laparoscopic instruments: technical considerations and surgical outcomes. Asian J Surg 38(1):6–12. https://doi.org/10.1016/j.asjsur.2014.01.014CrossRefPubMed

15.

Walther MM, Reiter R, Keiser HR, Choyke PL, Venzon D, Hurley K, Gnarra JR, Reynolds JC, Glenn GM, Zbar B, Linehan WM (1999) Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma. J Urol 162(3 Pt 1):659–664CrossRef

16.

Fu B, Zhang X, Wang GX, Lang B, Ma X, Li HZ, Wang BJ, Shi TP, Ai X, Zhou HX, Zheng T (2011) Long-term results of a prospective, randomized trial comparing retroperitoneoscopic partial versus total adrenalectomy for aldosterone producing adenoma. J Urol 185(5):1578–1582. https://doi.org/10.1016/j.juro.2010.12.051CrossRefPubMed

17.

Walz MK, Peitgen K, Diesing D, Petersenn S, Janssen OE, Philipp T, Metz KA, Mann K, Schmid KW, Neumann HP (2004) Partial versus total adrenalectomy by the posterior retroperitoneoscopic approach: early and long-term results of 325 consecutive procedures in primary adrenal neoplasias. World J Surg 28(12):1323–1329. https://doi.org/10.1007/s00268-004-7667-yCrossRefPubMed

18.

Ishidoya S, Ito A, Sakai K, Satoh M, Chiba Y, Sato F, Arai Y (2005) Laparoscopic partial versus total adrenalectomy for aldosterone producing adenoma. J Urol 174(1):40–43. https://doi.org/10.1097/01.ju.0000162045.68387.c3CrossRefPubMed

19.

Brandao LF, Autorino R, Zargar H, Krishnan J, Laydner H, Akca O, Mir MC, Samarasekera D, Stein R, Kaouk J (2014) Robot-assisted laparoscopic adrenalectomy: step-by-step technique and comparative outcomes. Eur Urol 66(5):898–905. https://doi.org/10.1016/j.eururo.2014.04.003CrossRefPubMed

20.

Yiannakopoulou E (2016) Robotic assisted adrenalectomy: Surgical techniques, feasibility, indications, oncological outcome and safety. Int J Surg Lond Engl 28:169–172. https://doi.org/10.1016/j.ijsu.2016.02.089CrossRef

21.

Simone G, De Nunzio C, Ferriero M, Cindolo L, Brookman-May S, Papalia R, Sperduti I, Collura D, Leonardo C, Anceschi U, Tuderti G, Misuraca L, Dalpiaz O, Hatzl S, Lodde M, Trenti E, Pastore AL, Palleschi G, Lotrecchiano G, Salzano L, Carbone A, De Cobelli O, Tubaro A, Schips L, Zigeuner R, Tostain J, May M, Guaglianone S, Muto G, Gallucci M (2016) Trends in the use of partial nephrectomy for cT1 renal tumors: Analysis of a 10-yr European Multicenter dataset. Eur J Surg Oncol 42(11):1729–1735. https://doi.org/10.1016/j.ejso.2016.03.022CrossRefPubMed

22.

St Julien J, Ball D, Schulick R (2006) Robot-assisted cortical-sparing adrenalectomy in a patient with Von Hippel-Lindau disease and bilateral pheochromocytomas separated by 9 years. J Laparoendosc Adv Surg Tech Part A 16(5):473–477. https://doi.org/10.1089/lap.2006.16.473CrossRef

23.

Boris RS, Gupta G, Linehan WM, Pinto PA, Bratslavsky G (2011) Robot-assisted laparoscopic partial adrenalectomy: initial experience. Urology 77(4):775–780. https://doi.org/10.1016/j.urology.2010.07.501CrossRefPubMed

24.

Simone G, Anceschi U, Tuderti G, Misuraca L, Celia A, De Concilio B, Costantini M, Stigliano A, Minisola F, Ferriero M, Guaglianone S, Gallucci M (2019) Robot-assisted partial adrenalectomy for the treatment of conn's syndrome: surgical technique, and perioperative and functional outcomes. Eur Urol 75(5):811–816. https://doi.org/10.1016/j.eururo.2018.07.030CrossRefPubMed

25.

Asher KP, Gupta GN, Boris RS, Pinto PA, Linehan WM, Bratslavsky G (2011) Robot-assisted laparoscopic partial adrenalectomy for pheochromocytoma: the National Cancer Institute technique. Eur Urol 60(1):118–124. https://doi.org/10.1016/j.eururo.2011.03.046CrossRefPubMedPubMedCentral

Titel: Robotic enucleation of adrenal masses: technique and outcomes
verfasst von: Chen Ye
Yue Yang
Fei Guo
Fubo Wang
Chao Zhang
Bo Yang
Publikationsdatum: 10.07.2019
Verlag: Springer Berlin Heidelberg
Erschienen in: World Journal of Urology / Ausgabe 4/2020
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-019-02868-7

Neu im Fachgebiet Urologie

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Objectives

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2020

3D imaging applications for robotic urologic surgery: an ESUT YAUWP review

The evolution and resurgence of perineal prostatectomy in the robotic surgical era

Size does matter: ureteral stents with a smaller diameter show advantages regarding urinary symptoms, pain levels and general health

Quality improvement initiative to reduce variability and improve stewardship of antimicrobial prophylaxis for transrectal prostate needle biopsy

Role of phosphodiesterase inhibitors in stent-related symptoms: a systematic review and meta-analysis